Equity
Additional Paid-In Capital
Year-over-year, this metric declined by 100.0%, from $1.80M to $0.00. Over 5 years (FY 2020 to FY 2025), Additional Paid-In Capital shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase typically signals equity financing or the issuance of shares for employee compensation.
Detailed definition
This represents the amount of capital received from shareholders in excess of the par value of the common stock. It is g...
Peer comparison
High levels are common in growth-oriented tech companies that utilize stock-based compensation to attract talent.
Metric ID:
additional_paid_in_capitalHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $248.00M | $251.20M | $249.00M | $219.90M | $225.30M | $230.60M | $232.20M | $181.40M | $158.20M | $122.60M | $120.20M | $55.20M | $33.50M | $23.30M | $22.10M | $1.80M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +1.3% | -0.9% | -11.7% | +2.5% | +2.4% | +0.7% | -21.9% | -12.8% | -22.5% | -2.0% | -54.1% | -39.3% | -30.4% | -5.2% | -91.9% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | -9.2% | -8.2% | -6.7% | -17.5% | -29.8% | -46.8% | -48.2% | -69.6% | -78.8% | -81.0% | -81.6% | -96.7% | -100.0% | -100.0% | -100.0% | -100.0% |
Range$0.00 – $251.20M
CAGR-100.0%
Avg YoY Growth-60.9%
Median YoY Growth-74.2%
Current Streak13 quarters decline
Additional Paid-In Capital at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's additional paid-in capital?
- West Pharmaceutical Services (WST) reported additional paid-in capital of $0.00 in Q1 2026.
- How has West Pharmaceutical Services's additional paid-in capital changed year-over-year?
- West Pharmaceutical Services's additional paid-in capital decreased by 100.0% year-over-year, from $1.80M to $0.00.
- What is the long-term trend for West Pharmaceutical Services's additional paid-in capital?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's additional paid-in capital has grown at a -100.0% compound annual growth rate (CAGR), from $267.30M to $0.00.
- What does additional paid-in capital mean?
- Capital received from investors above the par value of the shares.